erlotinib has been researched along with sb 772077-b in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (sb 772077-b) | Trials (sb 772077-b) | Recent Studies (post-2010) (sb 772077-b) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 5 | 0 | 4 |
| Protein | Taxonomy | erlotinib (IC50) | sb 772077-b (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 0.0065 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.014 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 7 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.324 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 1.95 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 9.1 | |
| Rho-associated protein kinase 1 | Homo sapiens (human) | 0.0084 | |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.035 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 1.64 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 1.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balke-Want, H; Basu, D; Engel, J; Ercanoglu, MS; Rauh, D; Richters, A; Tesch, R; Thomas, RK | 1 |
1 other study(ies) available for erlotinib and sb 772077-b
| Article | Year |
|---|---|
Identification and further development of potent TBK1 inhibitors.
Topics: Animals; Cell Line; Drug Design; Humans; Macrophages; Mice; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Small Molecule Libraries; Structure-Activity Relationship | 2015 |